Related Experiment Video
Updated: Jun 5, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Ensemble and consensus approaches to prediction of recessive inheritance for missense variants in human disease
Ben O Petrazzini1, Daniel J Balick2, Iain S Forrest3
1The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract:
Mode of inheritance (MOI) is necessary for clinical interpretation of pathogenic variants; however, the majority of variants lack this information. Furthermore, variant effect predictors are fundamentally insensitive to recessive-acting diseases. Here, we present MOI-Pred, a variant pathogenicity prediction tool that accounts for MOI, and ConMOI, a consensus method that integrates variant MOI predictions from three independent tools. MOI-Pred integrates evolutionary and functional annotations to produce variant-level predictions that are sensitive to both dominant-acting and recessive-acting pathogenic variants. Both MOI-Pred and ConMOI show state-of-the-art performance on standard benchmarks. Importantly, dominant and recessive predictions from both tools are enriched in individuals with pathogenic variants for dominant- and recessive-acting diseases, respectively, in a real-world electronic health record (EHR)-based validation approach of 29,981 individuals. ConMOI outperforms its component methods in benchmarking and validation, demonstrating the value of consensus among multiple prediction methods. Predictions for all possible missense variants are provided in the "Data and code availability" section.
Insights
We developed MOI-Pred and ConMOI, tools that predict variant pathogenicity considering mode of inheritance (MOI). These tools improve variant interpretation for both dominant and recessive diseases, enhancing clinical genetic diagnostics.
Area of Science:
- Genetics and Genomics
- Bioinformatics
- Clinical Diagnostics
Background:
- Mode of inheritance (MOI) is crucial for interpreting pathogenic genetic variants, yet this information is often missing.
- Existing variant effect prediction tools struggle with identifying variants causing recessive-acting diseases.
- Accurate MOI determination is essential for precise clinical genetic variant interpretation.
Purpose of the Study:
- To develop computational tools that predict variant pathogenicity while accounting for mode of inheritance.
- To create a consensus method integrating multiple MOI prediction tools for improved accuracy.
- To validate the clinical utility of these tools using real-world electronic health record data.
Main Methods:
- Developed MOI-Pred, a tool integrating evolutionary and functional annotations for variant-level pathogenicity predictions.
- Created ConMOI, a consensus method combining predictions from three independent MOI prediction tools.
- Validated predictions using a large-scale electronic health record (EHR) dataset of 29,981 individuals.
Main Results:
- MOI-Pred and ConMOI demonstrate state-of-the-art performance on standard benchmarks.
- Predictions from both tools showed significant enrichment for pathogenic variants in dominant and recessive diseases.
- ConMOI outperformed its individual component methods in both benchmarking and EHR-based validation.
Conclusions:
- MOI-Pred and ConMOI effectively predict pathogenicity for both dominant and recessive variants.
- The consensus approach (ConMOI) enhances prediction accuracy and robustness.
- These tools represent a significant advancement in variant interpretation, aiding clinical genetic diagnostics.
Related Concept Videos
Incomplete Dominance
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pedigree Analysis
Genetic Lingo
Probability Laws
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...

